Equities

Nanologica AB (publ)

Nanologica AB (publ)

Actions
Basic MaterialsChemicals
  • Price (SEK)5.54
  • Today's Change-0.12 / -2.12%
  • Shares traded26.59k
  • 1 Year change-34.26%
  • Beta0.7551
Data delayed at least 15 minutes, as of Apr 24 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.

  • Revenue in SEK (TTM)1.44m
  • Net income in SEK-75.16m
  • Incorporated2004
  • Employees16.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Biome Technologies plc98.67m-14.78m50.93m27.00--3.00--0.5161-0.2921-0.29211.960.33311.703.938.09271,444.40-25.44-15.83-41.15-21.8735.0841.21-14.98-12.441.38-1.720.549--7.92-0.144841.14--25.09--
Altheora SA441.07m-20.75m70.13m287.00--0.44129.600.159-0.2133-0.21334.481.021.013.309.75132,804.90-4.74---7.97--52.66---4.70--0.9364-2.200.5499--9.58---642.54------
Carclo plc1.86bn-91.46m74.14m1.12k--0.79014.320.0398-0.0925-0.09251.880.09491.11--4.90123,848.60-5.450.3861-7.360.6107--58.35-4.910.42390.97841.030.84080.0011.56-0.3817-177.50---23.33--
Plasticos Compuestos SA534.63m-1.34m113.24m80.00--0.71812.820.2118-0.0099-0.00993.881.121.274.7536.66577,504.80-0.3183-1.66-0.4673-2.4819.2815.96-0.2503-1.300.277253.950.3814---10.362.2391.43---19.91--
Vladimirskiy Khimicheskiy Zavod PAO-11.60bn-11.60bn168.90m800.00--2.28----------127.72----------0.7956--1.75--9.30--0.33540.9844--0.21853.3539.547.5831.91-5.56-16.64--
Melamin dd Kocevje862.54m58.95m191.85m189.00----1.680.222412.6012.60185.4087.371.149.375.29--7.025.918.857.7519.8124.336.145.601.63--0.285816.5740.859.05108.6610.659.82--
RIAS A/S485.78m19.40m208.78m90.0012.450.83156.380.429854.2354.231,357.78811.761.247.974.99--4.944.846.186.1033.0632.283.993.762.0218.030.045459.19-7.552.63-26.2513.383.558.16
Nanologica AB (publ)1.44m-75.16m250.33m16.00------173.36-2.05-2.050.0394-0.05180.01250.73332.3290,250.00-64.81-42.66-72.77-49.58-5.1974.47-5,204.85-529.383.00-11.59-----7.20-19.03-36.08--47.76--
Nexam Chemical Holding AB192.58m-20.61m265.40m54.00--1.38--1.38-0.2547-0.25472.382.370.72312.565.403,566,241.00-7.74-5.14-9.15-5.9844.1340.82-10.70-7.101.41-10.920.1088---14.2211.27-79.78--10.64--
Itaconix PLC85.08m-16.61m270.19m17.00--2.23--3.18-0.0959-0.09590.49130.66860.89084.909.93371,710.20-17.39-31.53-24.53-49.9230.9830.17-19.53-36.135.20--0.1661--40.4654.9437.64------
Polygiene Group AB122.17m-22.65m288.56m45.00--0.4697--2.36-0.62-0.623.3416.820.19661.104.363,301,919.00-3.652.84-3.743.1968.1365.77-18.545.134.41--0.003---4.4321.28-74.54--78.37--
OrganoClick AB145.87m-15.77m313.44m42.00--7.03338.852.15-0.161-0.1611.490.45520.93033.008.533,473,119.00-9.03-15.65-20.83-29.1319.7017.72-9.70-22.550.3803-2.680.4756--26.7913.2264.48--13.42--
Pryme NV0.00-152.11m470.75m18.00---------3.52-3.520.00---------------------------------------189.43------
Data as of Apr 24 2024. Currency figures normalised to Nanologica AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

5.97%Per cent of shares held by top holders
HolderShares% Held
Swedbank Robur Fonder ABas of 29 Feb 20242.26m5.13%
Handelsbanken Fonder ABas of 31 Mar 2024211.69k0.48%
FCG Fonder ABas of 30 Jun 2022160.08k0.36%
Data from 31 Oct 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.